ZFP36-ferroptosis axis as a key renal protective pathway in diabetic kidney disease
Endocrine Journal · 2026 · 73 (8) · 923-937
DOI: 10.1507/endocrj.ej25-0648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Journal, 2026. Verfasst von Anni Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an 223300, China. Hauptthemen laut MEDLINE: Ferroptosis, Diabetic Nephropathies, Tristetraprolin, Kidney. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jiangsu Provincial Department of Science and Technology, Jiangsu Commission of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an 223300, China.
- Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing 210004, China.
Förderung
- Jiangsu Provincial Department of Science and Technology
- Jiangsu Commission of Health
Zitieren
APA
Li, A., Ye, Y., Cao, H., Hu, J., Shi, M., Zhang, J., Zhang, Y., Liu, Y., Gu, B., & Zhang, H. (2026). ZFP36-ferroptosis axis as a key renal protective pathway in diabetic kidney disease. Endocrine Journal, 73(8), 923-937. https://doi.org/10.1507/endocrj.ej25-0648
Vancouver
Li A, Ye Y, Cao H, Hu J, Shi M, Zhang J, et al. ZFP36-ferroptosis axis as a key renal protective pathway in diabetic kidney disease. Endocrine Journal. 2026;73(8):923-937. doi:10.1507/endocrj.ej25-0648
BibTeX
@article{Li2026,
author = {Li, Anni and Ye, Yuxuan and Cao, Huimin and Hu, Jiawei and Shi, Min and Zhang, Juan and Zhang, Yiyuan and Liu, Yuting and Gu, Bixia and Zhang, Hong},
title = {ZFP36-ferroptosis axis as a key renal protective pathway in diabetic kidney disease},
journal = {Endocrine Journal},
year = {2026},
volume = {73},
number = {8},
pages = {923--937},
doi = {10.1507/endocrj.ej25-0648}
}
EUVIMED